万里马(300591) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥84,317,163.17, a decrease of 32.50% compared to ¥124,921,172.84 in the same period last year[5] - The net loss attributable to shareholders for Q1 2025 was ¥12,920,188.08, representing a 113.35% increase in loss compared to ¥6,055,993.56 in the previous year[5] - The basic and diluted earnings per share for Q1 2025 were both -¥0.0318, a decrease of 113.42% compared to -¥0.0149 in the previous year[5] - Total operating revenue decreased to ¥84,317,163.17 from ¥124,921,172.84, representing a decline of approximately 32.4% year-over-year[16] - Net loss for the period was ¥12,409,817.88, compared to a net loss of ¥5,597,509.05 in the previous period, indicating a worsening of approximately 121.5%[17] Cash Flow - The net cash flow from operating activities was -¥52,994,121.82, a decline of 91.82% from -¥27,627,614.44 in the same period last year[5] - Operating cash inflow for the current period was $91,221,789.61, down 34% from $138,069,885.01 in the previous period[19] - Net cash outflow from operating activities was -$52,994,121.82, compared to -$27,627,614.44 in the prior period, indicating a worsening cash flow situation[19] - Total cash outflow from operating activities was $144,215,911.43, down 13% from $165,697,499.45 in the previous period[19] Assets and Liabilities - Total assets at the end of Q1 2025 were ¥755,463,456.02, a slight increase of 0.18% from ¥754,120,365.51 at the end of the previous year[5] - Total liabilities increased to ¥437,119,546.31 from ¥423,414,582.00, reflecting a rise of about 3.9%[14] - The total equity attributable to shareholders decreased by 4.10% to ¥300,995,573.68 compared to ¥313,867,817.68 at the end of the previous year[5] Research and Development - The company's R&D expenses for Q1 2025 were ¥3,950,350.84, down 46.65% from ¥7,405,178.70 in the same period last year[8] - Research and development expenses decreased to ¥3,950,350.84 from ¥7,405,178.70, a reduction of approximately 46.6% year-over-year[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 22,634[9] - The largest shareholder, Lin Dayao, holds 11.28% of shares, totaling 45,765,700 shares, with 20,000,000 shares pledged[9] - Lin Dazhou, the second-largest shareholder, owns 3.97% of shares, amounting to 16,086,800 shares, with 8,000,000 shares pledged[9] Inventory and Prepayments - The company reported a significant increase in prepayments, which rose by 176.69% to ¥29,016,128.39, primarily due to increased procurement payments[8] - The inventory level increased by 35.67% to ¥130,176,255.65, attributed to a rise in production orders[8] - Inventory rose significantly to ¥130,176,255.65 from ¥95,953,194.02, indicating an increase of approximately 35.5%[12] Cash and Equivalents - The company's cash and cash equivalents decreased to ¥102,425,646.04 from ¥158,476,718.50, reflecting a decline of approximately 35.4%[12] - The ending cash and cash equivalents balance decreased to $101,504,625.44 from $110,856,513.39, a decline of approximately 8%[20]